Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing

Abstract

Routine use of targeted next-generation sequencing for recurrent UPS can facilitate timely therapeutic decision-making.